Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study.
Clinical trial · EBioMedicine · 2019. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study.
Justice JN, Nambiar AM, Tchkonia T et al.
EBioMedicine · 2019
- PubMed ID
- 30616998
- Record checked
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.